Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Droplet-based functional CRISPR screening of cell-cell interactions by SPEAC-seq.

Autor: Faust Akl C; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Linnerbauer M; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Li Z; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Lee HG; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Clark IC; Department of Bioengineering, College of Engineering, California Institute for Quantitative Biosciences, QB3, University of California Berkeley, Berkeley, CA, USA., Wheeler MA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; The Broad Institute of Harvard and MIT, Cambridge, MA, USA.; The Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Quintana FJ; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. fquintana@rics.bwh.harvard.edu.; The Broad Institute of Harvard and MIT, Cambridge, MA, USA. fquintana@rics.bwh.harvard.edu.; The Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. fquintana@rics.bwh.harvard.edu.

Publikováno v: Nature protocols [Nat Protoc] 2024 Sep 26. Date of Electronic Publication: 2024 Sep 26.

Author Correction: Disease-associated astrocyte epigenetic memory promotes CNS pathology.

Autor: Lee HG; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Rone JM; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Li Z; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Akl CF; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Shin SW; Department of Bioengineering, College of Engineering, California Institute for Quantitative Biosciences, QB3, University of California Berkeley, Berkeley, CA, USA., Lee JH; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Flausino LE; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Pernin F; Neuroimmunology Unit, Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada., Chao CC; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Kleemann KL; School of Computing, University of Portsmouth, Portsmouth, UK., Srun L; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Illouz T; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Giovannoni F; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Charabati M; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Sanmarco LM; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Kenison JE; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Piester G; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA., Zandee SEJ; Neuroimmunology Research Lab, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada., Antel JP; Neuroimmunology Unit, Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada., Rothhammer V; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Neurology, University Hospital, Friedrich-Alexander University Erlangen Nuremberg, Erlangen, Germany., Wheeler MA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Prat A; Neuroimmunology Research Lab, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada., Clark IC; Department of Bioengineering, College of Engineering, California Institute for Quantitative Biosciences, QB3, University of California Berkeley, Berkeley, CA, USA., Quintana FJ; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. fquintana@rics.bwh.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. fquintana@rics.bwh.harvard.edu.; Gene Lay Institute of Immunology and Inflammation, Boston, MA, USA. fquintana@rics.bwh.harvard.edu.

Publikováno v: Nature [Nature] 2024 Jul; Vol. 631 (8020), pp. E8.

Acceptance of Digital Health Technologies in Palliative Care Patients.

Autor: Wicki S; Department of Radiation Oncology, Competence Center Palliative Care, University Hospital and University of Zurich, Zurich, Switzerland., Clark IC; Department of Radiation Oncology, Competence Center Palliative Care, University Hospital and University of Zurich, Zurich, Switzerland.; Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland., Amann M; Department of Radiation Oncology, Competence Center Palliative Care, University Hospital and University of Zurich, Zurich, Switzerland., Christ SM; Department of Radiation Oncology, Competence Center Palliative Care, University Hospital and University of Zurich, Zurich, Switzerland.; Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland., Schettle M; Department of Radiation Oncology, Competence Center Palliative Care, University Hospital and University of Zurich, Zurich, Switzerland., Hertler C; Department of Radiation Oncology, Competence Center Palliative Care, University Hospital and University of Zurich, Zurich, Switzerland., Theile G; Department of Radiation Oncology, Competence Center Palliative Care, University Hospital and University of Zurich, Zurich, Switzerland., Blum D; Department of Radiation Oncology, Competence Center Palliative Care, University Hospital and University of Zurich, Zurich, Switzerland.

Publikováno v: Palliative medicine reports [Palliat Med Rep] 2024 Jan 12; Vol. 5 (1), pp. 34-42. Date of Electronic Publication: 2024 Jan 12 (Print Publication: 2024).

Multiomic Single Cell Sequencing Identifies Stemlike Nature of Mixed Phenotype Acute Leukemia and Provides Novel Risk Stratification.

Autor: Peretz CAC; Divison of Hematology and Oncology, Department of Pediatrics, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA., Kennedy VE; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Walia A; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Delley CL; Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Koh A; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Tran E; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Clark IC; Bioengineering, University of California Berkeley, Berkeley, CA, USA., Hayford CE; Fluent Biosciences Inc., Watertown, MA., D'Amato C; Fluent Biosciences Inc., Watertown, MA., Xue Y; Fluent Biosciences Inc., Watertown, MA., Fontanez KM; Fluent Biosciences Inc., Watertown, MA., Roy R; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA., Logan AC; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Perl AE; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Abate A; Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA., Olshen A; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA., Smith CC; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 May 18. Date of Electronic Publication: 2023 May 18.